Stock Research for VIVO


Featured Broker: Ally Invest

Get the due diligence for another stock.


VIVO Stock Chart & Research Data

The VIVO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the VIVO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


VIVO Due diligence Resources & Stock Charts

The VIVO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View VIVO Detailed Price Forecast - CNN Money CNN View VIVO Detailed Summary - Google Finance
Yahoo View VIVO Detailed Summary - Yahoo! Finance Zacks View VIVO Stock Research & Analysis -

Stock Analysis

TradeIdeas View VIVO Trends & Analysis - Trade-Ideas Barrons View VIVO Major Holders - Barrons
NASDAQ View VIVO Call Transcripts - NASDAQ Seeking View VIVO Breaking News & Analysis - Seeking Alpha
Spotlight View VIVO Annual Report - OTC Report View VIVO OTC Short Report -
TradeKing View VIVO Fundamentals - TradeKing Charts View VIVO SEC Filings - Bar Chart
WSJ View Historical Prices for VIVO - The WSJ Morningstar View Performance/Total Return for VIVO - Morningstar
MarketWatch View the Analyst Estimates for VIVO - MarketWatch CNBC View the Earnings History for VIVO - CNBC
StockMarketWatch View the VIVO Earnings - StockMarketWatch MacroAxis View VIVO Buy or Sell Recommendations - MacroAxis
Bullish View the VIVO Bullish Patterns - American Bulls Short Pains View VIVO Short Pain Metrics -

Social Media Mentions

StockTwits View VIVO Stock Mentions - StockTwits PennyStocks View VIVO Stock Mentions - PennyStockTweets
Twitter View VIVO Stock Mentions - Twitter Invest Hub View VIVO Investment Forum News - Investor Hub
Yahoo View VIVO Stock Mentions - Yahoo! Message Board Seeking Alpha View VIVO Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for VIVO - Insider Cow View Insider Transactions for VIVO - Insider Cow
CNBC View VIVO Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for VIVO - OTC Markets
Yahoo View Insider Transactions for VIVO - Yahoo! Finance NASDAQ View Institutional Holdings for VIVO - NASDAQ

Stock Charts

FinViz View VIVO Stock Insight & Charts - StockCharts View VIVO Investment Charts -
BarChart View VIVO Stock Overview & Charts - BarChart Trading View View VIVO User Generated Charts - Trading View

Latest Financial News for VIVO

Meridian Gets FDA Clearance for New Neonatal Saliva CMV Test
Posted on Thursday December 06, 2018

Meridian Bioscience, Inc. (VIVO) today announced that it has received FDA clearance for its new Alethia™ CMV Molecular Amplification Test (formerly, the illumigene brand). This assay is designed to specifically detect congenital Cytomegalovirus (cCMV) infection in newborns from an easy-to-collect saliva sample. Alethia CMV is the first qualitative test in a molecular amplification format, FDA-cleared for cCMV testing in newborns.

Is Meridian Bioscience Inc (NASDAQ:VIVO) A High Quality Stock To Own?
Posted on Monday December 03, 2018

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On

FDA approves Meridian Bioscience's test for herpes in newborns
Posted on Friday November 30, 2018

The U.S. Food and Drug Administration approved on Friday the first test - a diagnostic from Meridian Bioscience Inc - to help detect a type of herpes virus in newborns. Meridian's Alethia CMV Assay Test System detects cytomegalovirus (CMV) DNA from saliva swabs and won approval for use in babies younger than 21 days of age infected during pregnancy. Over half of adults have been infected with CMV by the age of 40, according to the Centers for Disease Control and Prevention.

Meridian Bioscience Inc (VIVO) Files 10-K for the Fiscal Year Ended on September 30, 2018
Posted on Thursday November 29, 2018

Meridian Bioscience Inc is an integrated life science company. The dividend yield of Meridian Bioscience Inc stocks is 2.69%. Meridian Bioscience Inc had annual average EBITDA growth of 2.00% over the past ten years.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.